Enanta Pharmaceutica (ENTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 46,383 | 37,192 | 30,156 | 26,011 | 71,956 |
| Depreciation Amortization | -1,078 | -1,122 | -731 | -297 | 1,683 |
| Income taxes - deferred | -3,138 | -1,953 | -800 | -918 | 1,858 |
| Accounts receivable | 15,892 | 22,838 | 27,574 | -2,681 | -56,591 |
| Accounts payable and accrued liabilities | 1,791 | 1,639 | 2,886 | 124 | 1,317 |
| Other Working Capital | 11,491 | 14,279 | 21,129 | -424 | -61,787 |
| Other Operating Activity | 77 | -10,000 | -19,874 | 8,439 | 70,784 |
| Operating Cash Flow | $71,418 | $62,873 | $60,340 | $30,254 | $29,220 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -5,417 | -5,121 | -2,891 | -384 | -2,981 |
| Purchase Of Investment | -549,312 | -353,382 | -271,712 | -119,546 | -293,103 |
| Sale Of Investment | 468,065 | 324,047 | 254,994 | 98,999 | 260,682 |
| Investing Cash Flow | $-86,664 | $-34,456 | $-19,609 | $-20,931 | $-35,402 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -86 | -64 | -42 | -21 | -79 |
| Common Stock Issued | 6,848 | 6,139 | 5,627 | 1,161 | 6,244 |
| Other Financing Activity | -4,188 | -4,188 | -4,188 | 0 | -1,756 |
| Financing Cash Flow | $2,574 | $1,887 | $1,397 | $1,140 | $4,409 |
| Beginning Cash Position | 64,510 | 64,510 | 64,510 | 64,510 | 66,283 |
| End Cash Position | 51,838 | 94,814 | 106,638 | 74,973 | 64,510 |
| Net Cash Flow | $-12,672 | $30,304 | $42,128 | $10,463 | $-1,773 |
| Free Cash Flow | |||||
| Operating Cash Flow | 71,418 | 62,873 | 60,340 | 30,254 | 29,220 |
| Capital Expenditure | -5,417 | -5,121 | -2,891 | -384 | -2,981 |
| Free Cash Flow | 66,001 | 57,752 | 57,449 | 29,870 | 26,239 |